Quarterly report pursuant to Section 13 or 15(d)

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.23.3
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended
Sep. 30, 2023
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES  
Schedule of Accounts receivable

(In thousands)

September 30, 

December 31, 

2023

    

2022

Accounts receivable

$

8,508

$

4,331

Less: Reserves

(236)

(249)

$

8,272

$

4,082

Schedule of Deferred revenues

(In thousands)

September 30, 

December 31, 

    

Balance Sheet Location

2023

    

2022

Deferred revenue, current

Other accrued expenses and current liabilities

$

2,435

$

1,651

Deferred revenue, net of current portion

Contract liabilities, net of current portion

6,432

8,856

$

8,867

$

10,507

Schedule of Earnings Per Share, Basic and Diluted

The table below reconciles basic and diluted earnings (loss) per share of common stock:

(In thousands)

Three Months Ended

Nine Months Ended

September 30, 

September 30, 

    

2023

    

2022

    

2023

    

2022

Numerator:

 

  

 

  

 

  

 

  

Net income (loss) ─ basic

$

4,593

$

(3,577)

$

(12,422)

$

(7,822)

Net income (loss) ─ diluted

$

4,593

$

(3,577)

$

(12,422)

$

(7,822)

Denominator:

 

  

 

  

 

  

 

  

Weighted-average common shares ─ basic

 

34,583

 

34,390

 

34,497

 

34,339

Potential dilution from share-based awards

2,090

89

60

Weighted-average common and common share equivalents ─ diluted

 

36,673

 

34,479

 

34,497

 

34,399

Anti-dilutive share-based awards excluded from the calculation of diluted earnings (loss) per share

 

1,108

 

3,512

 

3,998

 

2,466